192 related articles for article (PubMed ID: 32375094)
1. Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis.
Blum RA; Tomlinson AR; Jetté N; Kwon CS; Easton A; Yeshokumar AK
Epilepsy Behav; 2020 Jul; 108():107088. PubMed ID: 32375094
[TBL] [Abstract][Full Text] [Related]
2. Assessment of care transitions and caregiver burden in anti-NMDA receptor encephalitis.
Tomlinson AR; Blum RA; Jetté N; Kwon CS; Easton A; Yeshokumar AK
Epilepsy Behav; 2020 Jul; 108():107066. PubMed ID: 32375097
[TBL] [Abstract][Full Text] [Related]
3. Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis.
Yeshokumar A; Gordon-Lipkin E; Arenivas A; Rosenfeld M; Patterson K; Blum R; Banwell B; Venkatesan A; Lancaster E; Panzer J; Probasco J
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35794025
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
Morgan A; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Ontaneda D; Punia V; Rae-Grant A; Galioto R; Kunchok A
Neurology; 2024 Feb; 102(4):e208019. PubMed ID: 38266213
[TBL] [Abstract][Full Text] [Related]
5. EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis.
Foff EP; Taplinger D; Suski J; Lopes MB; Quigg M
Clin EEG Neurosci; 2017 Jan; 48(1):48-53. PubMed ID: 27068513
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
7. The prognosis of late-onset anti-N-methyl-D-aspartate receptor encephalitis in China.
Sun Y; Ren G; Ren J; Shan W; Han X; Lian Y; Wang T; Wang Q
Acta Neurol Scand; 2022 Apr; 145(4):449-455. PubMed ID: 34918336
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
[TBL] [Abstract][Full Text] [Related]
9. Rate of Anti-NMDA Receptor Encephalitis in Ovarian Teratomas.
Li JH; Milla SS; Gombolay GY
Neuropediatrics; 2022 Apr; 53(2):133-135. PubMed ID: 34872133
[TBL] [Abstract][Full Text] [Related]
10. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
Wang D; Su S; Tan M; Wu Y; Wang S
Front Immunol; 2021; 12():665183. PubMed ID: 33912193
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Treatment and Early Rehabilitation Outcomes in Pediatric Patients With Anti-NMDA Receptor Encephalitis.
Alvarez G; Krentzel A; Vova J; Blackwell L; Howarth R
Arch Phys Med Rehabil; 2021 Mar; 102(3):406-412. PubMed ID: 33058859
[TBL] [Abstract][Full Text] [Related]
12. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study.
Nissen MS; Ørvik MS; Nilsson AC; Ryding M; Lydolph M; Blaabjerg M
J Neurol; 2022 Mar; 269(3):1618-1630. PubMed ID: 34351472
[TBL] [Abstract][Full Text] [Related]
13. Recognizing psychiatric presentations of anti-NMDA receptor encephalitis in children and adolescents: A synthesis of published reports.
Gurrera RJ
Psychiatry Clin Neurosci; 2019 May; 73(5):262-268. PubMed ID: 30653785
[TBL] [Abstract][Full Text] [Related]
14. Japanese Encephalitis Virus-Induced Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature.
Tian M; Li J; Lei W; Shu X
Neuropediatrics; 2019 Apr; 50(2):111-115. PubMed ID: 30620950
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis.
Hirose S; Hara M; Kamei S; Dalmau J; Nakajima H
J Neurol; 2022 May; 269(5):2486-2492. PubMed ID: 34613453
[TBL] [Abstract][Full Text] [Related]
16. Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.
Mizoguchi T; Hara M; Hirose S; Nakajima H
Front Immunol; 2022; 13():845272. PubMed ID: 35242143
[TBL] [Abstract][Full Text] [Related]
17. Disease course and psychosocial outcome for children and adolescents with anti-N-methyl-D-aspartate receptor encephalitis.
Depreitere J; Antrop I; Verhelst H
Clin Child Psychol Psychiatry; 2024 Apr; 29(2):648-660. PubMed ID: 37915202
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning in children and adolescents with anti-NMDA receptor encephalitis (anti-NMDARE).
Hageboutros K; Hattiangadi Thomas N; Hutchinson M; Banwell B; Baum KT
J Neurol; 2023 Jan; 270(1):402-412. PubMed ID: 36112199
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cognitive status in pediatric anti-NMDA receptor encephalitis during inpatient rehabilitation: A retrospective cohort.
Howarth R; Blackwell L; Gombolay G
J Neuroimmunol; 2023 Mar; 376():578048. PubMed ID: 36774765
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
